I am BIO Podcast

Powerful stories of biotech breakthroughs, the people they help, and the global problems they solve.

Join Our Email List

Listen on
Apple Podcast

Listen on
Google Podcast

Listen on
Spotify

Featured Episodes & More

Is CRISPR the New Sickle Cell Savior?

A 2023 biotech breakthrough: CRISPR gene-editing therapy offers new hope for 100,000 Americans with sickle cell. Hear from CASGEVY's creators and patient advocates in this episode.

Listen Now

Biotech is Climate Tech

Biotech tackles climate change with innovations, from carbon-neutral facilities to reducing emissions. At COP28, BIO highlighted that biotech is key to climate tech.

Learn More

Editing Cells Within the Body—a New CRISPR Frontier

CRISPR, biotech's rising star, reached a 2023 milestone with FDA approval for a sickle cell treatment. This episode explores the future of in-body gene editing with two pioneering companies.

Learn More

Listener takeover: Your Biotech Questions Answered

In this episode, experts answer your questions on GMO safety, personalized medicine, feeding the world by 2050, and what attracts investors to start-ups.

Learn More

Investors Become Goldilocks in a Bear Market

Episode 60 • May 31, 2022 • 25 min

Current market trends have put investors in a “flight-to-safety” mentality, especially when it comes to biotech companies. What does this mean for getting biotech innovations to the marketplace? This episode explores the daunting challenge of raising capital in a bear market.

Listen Now

Drug Prices: A Dysfunctional Market Limits Patient Access

Episode 59 • May 17, 2022 • 26 min

A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.